Cargando…

Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for Acute ST elevation MI: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Clinical trials comparing thrombectomy devices with conventional percutaneous coronary interventions (PCI) in patients with acute ST elevation myocardial infarction (STEMI) have produced conflicting results. The objective of our study was to systematically evaluate currently available da...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamhane, Umesh U, Chetcuti, Stanley, Hameed, Irfan, Grossman, P Michael, Moscucci, Mauro, Gurm, Hitinder S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838805/
https://www.ncbi.nlm.nih.gov/pubmed/20187958
http://dx.doi.org/10.1186/1471-2261-10-10
_version_ 1782178889766797312
author Tamhane, Umesh U
Chetcuti, Stanley
Hameed, Irfan
Grossman, P Michael
Moscucci, Mauro
Gurm, Hitinder S
author_facet Tamhane, Umesh U
Chetcuti, Stanley
Hameed, Irfan
Grossman, P Michael
Moscucci, Mauro
Gurm, Hitinder S
author_sort Tamhane, Umesh U
collection PubMed
description BACKGROUND: Clinical trials comparing thrombectomy devices with conventional percutaneous coronary interventions (PCI) in patients with acute ST elevation myocardial infarction (STEMI) have produced conflicting results. The objective of our study was to systematically evaluate currently available data comparing thrombectomy followed by PCI with conventional PCI alone in patients with acute STEMI. METHODS: Seventeen randomized trials (n = 3,909 patients) of thrombectomy versus PCI were included in this meta-analysis. We calculated the summary odds ratios for mortality, stroke, post procedural myocardial blush grade (MBG), thrombolysis in myocardial infarction (TIMI) grade flow, and post procedural ST segment resolution (STR) using random-effects and fixed-effects models. RESULTS: There was no difference in risk of 30-day mortality (44/1914 vs. 50/1907, OR 0.84, 95% CI 0.54-1.29, P = 0.42) among patients randomized to thrombectomy, compared with conventional PCI. Thrombectomy was associated with a significantly greater likelihood of TIMI 3 flow (1616/1826 vs. 1533/1806, OR 1.41, P = 0.007), MBG 3 (730/1526 vs. 486/1513, OR 2.42, P < 0.001), STR (923/1500 vs. 715/1494, OR 2.30, P < 0.001), and with a higher risk of stroke (14/1403 vs. 3/1413, OR 2.88, 95% CI 1.06-7.85, P = 0.04). Outcomes differed significantly between different device classes with a trend towards lower mortality with manual aspiration thrombectomy (MAT) (21/949 vs.36/953, OR 0.59, 95% CI 0.35-1.01, P = 0.05), whereas mechanical devices showed a trend towards higher mortality (20/416 vs.10/418, OR 2.07, 95% CI 0.95-4.48, P = 0.07). CONCLUSIONS: Thrombectomy devices appear to improve markers of myocardial perfusion in patients undergoing primary PCI, with no difference in overall 30-day mortality but an increased likelihood of stroke. The clinical benefits of thrombectomy appear to be influenced by the device type with a trend towards survival benefit with MAT and worsening outcome with mechanical devices.
format Text
id pubmed-2838805
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28388052010-03-16 Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for Acute ST elevation MI: A Meta-Analysis of Randomized Controlled Trials Tamhane, Umesh U Chetcuti, Stanley Hameed, Irfan Grossman, P Michael Moscucci, Mauro Gurm, Hitinder S BMC Cardiovasc Disord Research article BACKGROUND: Clinical trials comparing thrombectomy devices with conventional percutaneous coronary interventions (PCI) in patients with acute ST elevation myocardial infarction (STEMI) have produced conflicting results. The objective of our study was to systematically evaluate currently available data comparing thrombectomy followed by PCI with conventional PCI alone in patients with acute STEMI. METHODS: Seventeen randomized trials (n = 3,909 patients) of thrombectomy versus PCI were included in this meta-analysis. We calculated the summary odds ratios for mortality, stroke, post procedural myocardial blush grade (MBG), thrombolysis in myocardial infarction (TIMI) grade flow, and post procedural ST segment resolution (STR) using random-effects and fixed-effects models. RESULTS: There was no difference in risk of 30-day mortality (44/1914 vs. 50/1907, OR 0.84, 95% CI 0.54-1.29, P = 0.42) among patients randomized to thrombectomy, compared with conventional PCI. Thrombectomy was associated with a significantly greater likelihood of TIMI 3 flow (1616/1826 vs. 1533/1806, OR 1.41, P = 0.007), MBG 3 (730/1526 vs. 486/1513, OR 2.42, P < 0.001), STR (923/1500 vs. 715/1494, OR 2.30, P < 0.001), and with a higher risk of stroke (14/1403 vs. 3/1413, OR 2.88, 95% CI 1.06-7.85, P = 0.04). Outcomes differed significantly between different device classes with a trend towards lower mortality with manual aspiration thrombectomy (MAT) (21/949 vs.36/953, OR 0.59, 95% CI 0.35-1.01, P = 0.05), whereas mechanical devices showed a trend towards higher mortality (20/416 vs.10/418, OR 2.07, 95% CI 0.95-4.48, P = 0.07). CONCLUSIONS: Thrombectomy devices appear to improve markers of myocardial perfusion in patients undergoing primary PCI, with no difference in overall 30-day mortality but an increased likelihood of stroke. The clinical benefits of thrombectomy appear to be influenced by the device type with a trend towards survival benefit with MAT and worsening outcome with mechanical devices. BioMed Central 2010-02-26 /pmc/articles/PMC2838805/ /pubmed/20187958 http://dx.doi.org/10.1186/1471-2261-10-10 Text en Copyright ©2010 Tamhane et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Tamhane, Umesh U
Chetcuti, Stanley
Hameed, Irfan
Grossman, P Michael
Moscucci, Mauro
Gurm, Hitinder S
Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for Acute ST elevation MI: A Meta-Analysis of Randomized Controlled Trials
title Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for Acute ST elevation MI: A Meta-Analysis of Randomized Controlled Trials
title_full Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for Acute ST elevation MI: A Meta-Analysis of Randomized Controlled Trials
title_fullStr Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for Acute ST elevation MI: A Meta-Analysis of Randomized Controlled Trials
title_full_unstemmed Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for Acute ST elevation MI: A Meta-Analysis of Randomized Controlled Trials
title_short Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for Acute ST elevation MI: A Meta-Analysis of Randomized Controlled Trials
title_sort safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute st elevation mi: a meta-analysis of randomized controlled trials
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838805/
https://www.ncbi.nlm.nih.gov/pubmed/20187958
http://dx.doi.org/10.1186/1471-2261-10-10
work_keys_str_mv AT tamhaneumeshu safetyandefficacyofthrombectomyinpatientsundergoingprimarypercutaneouscoronaryinterventionforacutestelevationmiametaanalysisofrandomizedcontrolledtrials
AT chetcutistanley safetyandefficacyofthrombectomyinpatientsundergoingprimarypercutaneouscoronaryinterventionforacutestelevationmiametaanalysisofrandomizedcontrolledtrials
AT hameedirfan safetyandefficacyofthrombectomyinpatientsundergoingprimarypercutaneouscoronaryinterventionforacutestelevationmiametaanalysisofrandomizedcontrolledtrials
AT grossmanpmichael safetyandefficacyofthrombectomyinpatientsundergoingprimarypercutaneouscoronaryinterventionforacutestelevationmiametaanalysisofrandomizedcontrolledtrials
AT moscuccimauro safetyandefficacyofthrombectomyinpatientsundergoingprimarypercutaneouscoronaryinterventionforacutestelevationmiametaanalysisofrandomizedcontrolledtrials
AT gurmhitinders safetyandefficacyofthrombectomyinpatientsundergoingprimarypercutaneouscoronaryinterventionforacutestelevationmiametaanalysisofrandomizedcontrolledtrials